Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 53
Filtrar
1.
Genet Med ; 23(4): 645-652, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33244165

RESUMEN

PURPOSE: MED12 is a subunit of the Mediator multiprotein complex with a central role in RNA polymerase II transcription and regulation of cell growth, development, and differentiation. This might underlie the variable phenotypes in males carrying missense variants in MED12, including X-linked recessive Ohdo, Lujan, and FG syndromes. METHODS: By international matchmaking we assembled variant and clinical data on 18 females presenting with variable neurodevelopmental disorders (NDDs) and harboring de novo variants in MED12. RESULTS: Five nonsense variants clustered in the C-terminal region, two splice variants were found in the same exon 8 splice acceptor site, and 11 missense variants were distributed over the gene/protein. Protein truncating variants were associated with a severe, syndromic phenotype consisting of intellectual disability (ID), facial dysmorphism, short stature, skeletal abnormalities, feeding difficulties, and variable other abnormalities. De novo missense variants were associated with a less specific, but homogeneous phenotype including severe ID, autistic features, limited speech and variable other anomalies, overlapping both with females with truncating variants as well as males with missense variants. CONCLUSION: We establish de novo truncating variants in MED12 as causative for a distinct NDD and de novo missense variants as causative for a severe, less specific NDD in females.


Asunto(s)
Discapacidad Intelectual , Complejo Mediador/genética , Discapacidad Intelectual Ligada al Cromosoma X , Trastornos del Neurodesarrollo , Femenino , Genes Ligados a X , Humanos , Discapacidad Intelectual/genética , Discapacidad Intelectual Ligada al Cromosoma X/genética , Mutación Missense , Trastornos del Neurodesarrollo/genética , Fenotipo , Síndrome
2.
Carbohydr Polym ; 230: 115600, 2020 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-31887872

RESUMEN

Kinetics of chitosan depolymerization were studied in dilute acetic acid solution, in presence of H-Mordenite (H-MOR). Rate constants for chitosan depolymerization were determined by measurement of molecular weight, using Gel permeation Chromatography (GPC). Depolymerization rate of chitosan was altered in presence of an acidic, porous material like H-MOR. Maximum concentration of H-MOR studied during process led to minimal increase in energy of activation, from 20.54 kJ/moL to 23.25 kJ/moL. Infra-red spectroscopy, adsorption studies and rheological assessment indicated adsorption /grafting of chitosan onto porous H-MOR surface as the possible mechanism for facilitation of the depolymerization process. Under extreme conditions investigated during process optimization, H-MOR resulted in a three-fold reduction in 5-Hydroxy Methyl Furfural (5-HMF) formation and over ten times decrease in glucosamine content, as compared to reactions conducted without H-MOR. Therefore, presence of H-MOR is imperative to cleave chitosan in controlled manner and obtain products of desired molecular weight, with fewer impurities.


Asunto(s)
Silicatos de Aluminio/química , Quitosano/análogos & derivados , Ácidos/química , Tecnología Química Verde/métodos , Cinética , Polimerizacion
3.
Case Rep Hematol ; 2018: 3915319, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29850299

RESUMEN

Rosai-Dorfman disease (RDD) is a rare, nonmalignant disorder of histiocyte proliferation typically involving the cervical lymph nodes. However, a subset of patients with RDD will display extranodal manifestations that are highly variable in presentation, more challenging to diagnose, and less likely to spontaneously regress compared to nodal disease. While case reports of extranodal involvement in nearly every organ system exist, documented instances of mediastinal and pulmonary artery involvement are particularly rare. This study describes the case of a middle-aged woman presenting with new onset right heart failure who was found to have extranodal RDD in the form of a large mediastinal mass with invasion and occlusion of the main pulmonary arteries.

4.
J Med Genet ; 54(8): 537-543, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28100473

RESUMEN

BACKGROUND: Bainbridge-Ropers syndrome (BRPS) is a recently described developmental disorder caused by de novo truncating mutations in the additional sex combs like 3 (ASXL3) gene. To date, there have been fewer than 10 reported patients. OBJECTIVES: Here, we delineate the BRPS phenotype further by describing a series of 12 previously unreported patients identified by the Deciphering Developmental Disorders study. METHODS: Trio-based exome sequencing was performed on all 12 patients included in this study, which found a de novo truncating mutation in ASXL3. Detailed phenotypic information and patient images were collected and summarised as part of this study. RESULTS: By obtaining genotype:phenotype data, we have been able to demonstrate a second mutation cluster region within ASXL3. This report expands the phenotype of older patients with BRPS; common emerging features include severe intellectual disability (11/12), poor/ absent speech (12/12), autistic traits (9/12), distinct face (arched eyebrows, prominent forehead, high-arched palate, hypertelorism and downslanting palpebral fissures), (9/12), hypotonia (11/12) and significant feeding difficulties (9/12) when young. DISCUSSION: Similarities in the patients reported previously in comparison with this cohort included their distinctive craniofacial features, feeding problems, absent/limited speech and intellectual disability. Shared behavioural phenotypes include autistic traits, hand-flapping, rocking, aggressive behaviour and sleep disturbance. CONCLUSIONS: This series expands the phenotypic spectrum of this severe disorder and highlights its surprisingly high frequency. With the advent of advanced genomic screening, we are likely to identify more variants in this gene presenting with a variable phenotype, which this study will explore.


Asunto(s)
Discapacidades del Desarrollo/genética , Discapacidades del Desarrollo/patología , Mutación con Pérdida de Función/genética , Fenotipo , Factores de Transcripción/genética , Adulto , Niño , Preescolar , Discapacidades del Desarrollo/fisiopatología , Femenino , Humanos , Masculino , Secuenciación del Exoma , Adulto Joven
5.
Clin Exp Dermatol ; 38(7): 737-40, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24073655

RESUMEN

Variegate porphyria is an autosomal dominant disorder that usually presents with photosensitivity and acute neurological crises in adulthood. It is caused by heterozygous mutations in the protoporphyrinogen oxidase gene (PPOX). A rarer variant, homozygous variegate porphyria (HVP), presents in childhood with recurrent skin blisters and scarring. More variable features of HVP are short stature, brachydactyly, nystagmus, epilepsy, developmental delay and mental retardation. We describe a child who presented with nystagmus, developmental delay and ataxia, combined with a photosensitive eruption. Analysis of porphyrins in plasma, urine and stool supported a clinical diagnosis of HVP. DNA from the patient showed that he is compound heterozygous for two novel missense mutations in the PPOX coding region: c.169G>C (p.Gly57Arg) and c.1259C>G (Pro420Arg). Interestingly, cranial magnetic resonance imaging showed an absence of myelin, a feature not previously reported in HVP, which expands the differential diagnosis of childhood hypomyelinating leucoencephalopathies.


Asunto(s)
Discapacidades del Desarrollo/diagnóstico , Trastornos del Desarrollo del Lenguaje/diagnóstico , Porfiria Variegata/diagnóstico , Ataxia/diagnóstico , Preescolar , Humanos , Masculino , Nistagmo Congénito/diagnóstico , Trastornos por Fotosensibilidad/diagnóstico , Porfiria Variegata/genética , Protoporfirinógeno-Oxidasa/genética
6.
Ann Med Health Sci Res ; 3(3): 341-4, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24116310

RESUMEN

BACKGROUND: Improvements in technology have increased the chances of survival for the micro-premature infant and the very low birth-weight infant but have significantly increased the financial burden of health care organizations. This economic burden has a significant impact on third-party payers and on society in general. AIM: The study was designed to assess yoga therapy (YT) module on maternal stress level in high risk pregnancy. SUBJECTS AND METHODS: In the present study, sixty-eight pregnant women (38 in the control group with standard antenatal care and 30 in the YT group) with 27.2 (5.2) years of mean age recruited from the outpatient services of medical college and hospital in Bangalore, South India, were participated. The study was a single-blind randomized controlled clinical trial. Perceived stress scale (PSS) was measured during the 12(th), 20(th), and 28(th) weeks of pregnancy. SPSS version 16.0 (Chicago, IL, USA) was used for all data analysis. When the data were found to be normally distributed, the RMANOVA were used to assess the PSS scores between the yoga and control groups. Significant values were set at P < 0.05. RESULTS: There was a significant difference in the PSS level of the YT group with significantly reduced scores at the second follow-up (28(th) week of pregnancy) compared to the control group (P = 0.02). Women who took part in the YT module reported significantly fewer pregnancy discomforts decrease in PSS (P = 0.02) than the control group where the stress level was increased (RMANOVA test using SPSS-16). CONCLUSION: The present study suggests that the YT module can decrease the stress level during high-risk pregnancy complications. Thus, practicing YT during high-risk pregnancy is not only a cost-effective option but also a feasible and safe option. Additional well-designed studies are needed before a strong recommendation can be made.

7.
Clin Genet ; 84(6): 539-45, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23320472

RESUMEN

Recently, pathogenic variants in the MLL2 gene were identified as the most common cause of Kabuki (Niikawa-Kuroki) syndrome (MIM#147920). To further elucidate the genotype-phenotype correlation, we studied a large cohort of 86 clinically defined patients with Kabuki syndrome (KS) for mutations in MLL2. All patients were assessed using a standardized phenotype list and all were scored using a newly developed clinical score list for KS (MLL2-Kabuki score 0-10). Sequencing of the full coding region and intron-exon boundaries of MLL2 identified a total of 45 likely pathogenic mutations (52%): 31 nonsense, 10 missense and four splice-site mutations, 34 of which were novel. In five additional patients, novel, i.e. non-dbSNP132 variants of clinically unknown relevance, were identified. Patients with likely pathogenic nonsense or missense MLL2 mutations were usually more severely affected (median 'MLL2-Kabuki score' of 6) as compared to the patients without MLL2 mutations (median 'MLL2-Kabuki score' of 5), a significant difference (p < 0.0014). Several typical facial features such as large dysplastic ears, arched eyebrows with sparse lateral third, blue sclerae, a flat nasal tip with a broad nasal root, and a thin upper and a full lower lip were observed more often in mutation positive patients.


Asunto(s)
Anomalías Múltiples/diagnóstico , Anomalías Múltiples/genética , Proteínas de Unión al ADN/genética , Cara/anomalías , Estudios de Asociación Genética , Enfermedades Hematológicas/diagnóstico , Enfermedades Hematológicas/genética , Mutación , Proteínas de Neoplasias/genética , Enfermedades Vestibulares/diagnóstico , Enfermedades Vestibulares/genética , Facies , Femenino , Humanos , Masculino , Fenotipo , Análisis de Secuencia de ADN
8.
Diagn Cytopathol ; 41(4): 316-23, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22102479

RESUMEN

Epidermal growth factor receptor (EGFR) mutation status has been shown to predict response to anti-EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC). In patients with advanced-stage NSCLC, evaluation of mutational status is increasingly requested on biopsy or fine-needle aspiration specimens, which often have limited material. There are limited data on the suitability of cytology cell blocks (CB) for EGFR mutation testing. In this study, we report our institutional experience with cytology cell block material for EGFR mutation testing. We retrospectively reviewed EGFR mutation analyses performed on 234 surgical (SP) and cytology (CB) from October 2007 to May 2010. One hundred ninety-two SP specimens and 42 CB specimens were evaluated for EGFR mutation. CB specimens were evaluated for overall specimen size based on aggregate cellularity in comparison to small biopsy specimens, and percent tumor. Of the 192 SP and 42 CB specimens, 31 (16.1%) and 11 (26.2%) were positive for EGFR mutation, respectively; there does not appear to be an association between mutation detection rate and the source of the specimen (P = 0.124). Limited DNA was obtained from 70.0% (29/42), including 81.8% (9/11) of those which were mutation positive. Additionally, 45.4% (5/11) of mutation positive specimens had extremely low DNA yields. Although 16.6% (7/42) of CB specimens had <10% tumor, all 11 mutation positive CB cases had >10% tumor. These data indicate that CB specimens provide an alternative source for molecular evaluation of NSCLC, and that tumor percentage may be more important than specimen size and/or DNA yield in determining the suitability of these specimens for testing.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , ADN de Neoplasias/análisis , Receptores ErbB/genética , Mutación , Adulto , Anciano , Anciano de 80 o más Años , Biopsia con Aguja Fina , Carcinoma de Pulmón de Células no Pequeñas/genética , Análisis Mutacional de ADN , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tasa de Mutación , Estudios Retrospectivos , Sensibilidad y Especificidad
9.
Middle East J Anaesthesiol ; 21(5): 747-50, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23265042

RESUMEN

Aortoarteritis (Takayasu's Disease) is an inflammatory involvement of Aorta, Pulmonary artery and their large branches and is associated with high perioperative morbidity and mortality. Administration of safe anesthesia to these high risk patients is a challenge and requires knowledge of disease pathophysiology, associated end organ dysfunction, monitoring requirements, potential complications of the disease and medical therapy. We present a case report of a patient posted for auto renal transplantation conducted under combined general and epidural anesthesia and discuss the several advantageous of this technique.


Asunto(s)
Aneurisma de la Aorta Abdominal/complicaciones , Trasplante de Riñón , Arteritis de Takayasu/complicaciones , Adulto , Anestesia Epidural , Anestesia General , Aneurisma de la Aorta Abdominal/cirugía , Femenino , Humanos , Arteritis de Takayasu/cirugía , Trasplante Autólogo
10.
Indian J Anaesth ; 53(4): 455-62, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20640208

RESUMEN

SUMMARY: A perioperative anaesthetic management that aims to facilitate tracheal extubation of patients within 1-6 hrs after cardiac surgery is called "fast-track". Main advantage of "fast-track" method is better usage of medical resources and lowering hospital costs without increasing morbidity and mortality of the patients. Standard fast-track protocols contain short acting anaesthetic agents, smaller incisions and decreased pump times without hypothermia. In this study we compared two short acting opioid drugs, fentanyl versus Sufentanil when used as a part of the balanced anaesthesia technique for fast track in cardiac surgery patients & evaluated the time taken for extubation, haemodynamic stability, analgesia requirements & incidence of awareness. The results from the study show that both agents provide good haemodynamic stability and postoperative analgesia. Although Sufentanil provides earlier extubation, both agents reduce the ICU stay equally. In conclusion both agents can be used effectively for fasttrack cardiac anaesthesia.

11.
J Biomech Eng ; 130(3): 031012, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18532861

RESUMEN

Vascular reactivity (VR) denotes changes in volumetric blood flow in response to arterial occlusion. Current techniques to study VR rely on monitoring blood flow parameters and serve to predict the risk of future cardiovascular complications. Because tissue temperature is directly impacted by blood flow, a simplified thermal model was developed to study the alterations in fingertip temperature during arterial occlusion and subsequent reperfusion (hyperemia). This work shows that fingertip temperature variation during VR test can be used as a cost-effective alternative to blood perfusion monitoring. The model developed introduces a function to approximate the temporal alterations in blood volume during VR tests. Parametric studies are performed to analyze the effects of blood perfusion alterations, as well as any environmental contribution to fingertip temperature. Experiments were performed on eight healthy volunteers to study the thermal effect of 3 min of arterial occlusion and subsequent reperfusion (hyperemia). Fingertip temperature and heat flux were measured at the occluded and control fingers, and the finger blood perfusion was determined using venous occlusion plethysmography (VOP). The model was able to phenomenologically reproduce the experimental measurements. Significant variability was observed in the starting fingertip temperature and heat flux measurements among subjects. Difficulty in achieving thermal equilibration was observed, which indicates the important effect of initial temperature and thermal trend (i.e., vasoconstriction, vasodilatation, and oscillations).


Asunto(s)
Regulación de la Temperatura Corporal/fisiología , Dedos/irrigación sanguínea , Dedos/fisiopatología , Hiperemia/fisiopatología , Modelos Biológicos , Temperatura Cutánea , Brazo/fisiopatología , Velocidad del Flujo Sanguíneo/fisiología , Monitores de Presión Sanguínea , Transferencia de Energía/fisiología , Calor , Humanos , Isquemia/fisiopatología , Pletismografía , Flujo Sanguíneo Regional , Conductividad Térmica , Factores de Tiempo , Vasoconstricción/fisiología , Vasodilatación/fisiología
13.
Indian J Pharm Sci ; 70(1): 56-60, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20390081

RESUMEN

In a recent study, it has been demonstrated that ascorbic acid possessed antidopaminergic activity and modulate the glutamatergic neurotransmission in mice. With this background, the present study was undertaken to study the effect of ascorbic acid on the development of tolerance and dependence to opiate and its mechanism of action. Male Swiss mice weighing 20-25 g were used in the present study. Mice were made physically dependent on opioid by the chronic administration of morphine (10 mg/kg, twice a day, for 9 days) intraperitoneally. Ascorbic acid, haloperidol (dopamine antagonist) or MK 801 (NMDA receptor antagonist) was administered daily for 9 d before challenging the animals with morphine. The development of tolerance was assessed by noting the tail-flick latency on day 1, 3, 9 and 10. On the 10(th) day after the measurement of tail-flick latency, animals were challenged with naloxone (2 mg/kg., i.p.) and incidence of escape jumps were recorded by placing the animals in 45 cm high plexiglass container. Ascorbic acid (400-1600 mg/kg) dose dependently inhibited development of tolerance and dependence to morphine as noted from tail-flick latency. When given along with MK 801 (0.01 mg/kg., i.p) or haloperidol (0.1 mg/kg i.p.), ascorbic acid (800 mg/kg., i.p.) potentiated the response of MK 801 or haloperidol. In conclusion, it is hypothesized that inhibition of development of tolerance and dependence to morphine by ascorbic acid appears to have two components, namely dopaminergic and glutamatergic.

14.
Semin Fetal Neonatal Med ; 13(3): 171-80, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18162447

RESUMEN

Renal anomalies are frequently detected on the routine second trimester scan offered to all pregnant women in the UK. These anomalies may be isolated but can also be associated with other congenital anomalies. Many combinations of ultrasound scan findings constitute recognised genetic entities. Knowledge of these conditions is essential for adequate management of the pregnancy and subsequent balanced parental counselling. This short review discusses the common genetic syndromes associated with the renal abnormalities identified on the antenatal ultrasound scan, and also provides an overview of renal symptoms in chromosome imbalances and after teratogenic influences.


Asunto(s)
Feto/anomalías , Enfermedades Genéticas Congénitas/diagnóstico , Riñón/anomalías , Síndrome de Beckwith-Wiedemann/diagnóstico , Aberraciones Cromosómicas , Femenino , Humanos , Riñón/diagnóstico por imagen , Oligohidramnios/epidemiología , Oligohidramnios/fisiopatología , Polihidramnios/etiología , Embarazo , Segundo Trimestre del Embarazo , Diagnóstico Prenatal , Síndrome , Ultrasonografía Prenatal
15.
J Hazard Mater ; 137(3): 1395-401, 2006 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-16730902

RESUMEN

The standard sampling methods for toluene diisocyanate (TDI) only collect total TDI without separating the aerosol and gas phases. There are few other samplers, such as the dual filter, triple filter and annular denuder systems (ADS), which are able to sample the aerosol and gas phases simultaneously. This field study was conducted at two workplaces to access the total 2,4-TDI and the gaseous and aerosol TDI concentrations by different samplers simultaneously. In addition to the standard sampling time of 15 min, sampling was done for 30 and 60 min to study the effect of sampling time on the measured 2,4-TDI concentrations. Test results at two workplaces show that gas-phase 2,4-TDI is the predominant species and the aerosol phase concentration is very small. The measurements using various samplers show that the sampling time influences the sampled TDI concentration considerably which may be due to reaction of TDI with water vapor and polyo in the sampling process. It is evident that as sampling time increases the TDI concentration decreases. Laboratory test was also conducted using pure gas-phase 2,4-TDI to confirm the sampling time effect on the measured concentrations found in the field study.


Asunto(s)
2,4-Diisocianato de Tolueno/análisis
16.
Sci Total Environ ; 356(1-3): 38-44, 2006 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-15885752

RESUMEN

The main objective of this study is to investigate the personal or area exposure of organic solvents during paint stripping and paint spraying. Three aircraft paint stripping/spraying workplaces in Taiwan were selected, and the Council of Labor Affairs and NIOSH recommended sampling/analytical methods used in this study. Activated charcoal tubes were used to investigate the personal and area exposure concentration of organic solvents in paint stripping and paint spraying operations. During aircraft paint stripping, experiment results show that methylene chloride personal exposure concentration at the ground area, 42.01+/-31.86 ppm, is higher than that at the working platform 4 M high above the ground, 20.41+/-11.43 ppm. Exposure concentration of methylene chloride in the initial paint stripping operation stage of every workplace is over the PEL (50 ppm) set by the Taiwan Council of Labor Affairs. Corrective actions are needed. During paint spraying, concentrations of all organic solvents were found to be below the PEL of OSHA.


Asunto(s)
Contaminantes Ocupacionales del Aire/análisis , Aeronaves , Exposición Profesional/análisis , Pintura , Solventes/análisis , Aeronaves/normas , Humanos , Taiwán , Lugar de Trabajo/normas
17.
Lab Invest ; 82(9): 1193-9, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12218080

RESUMEN

Epstein-Barr virus (EBV), a gamma herpesvirus, has been associated with a variety of human malignancies such as Burkitt's lymphoma, Hodgkin's lymphoma, NPC, and gastric cancer. A controversy regarding the association of EBV with breast cancers has recently been reported in the literature. These reports have mainly used the DNA detection techniques of polymerase chain reaction and Southern blot hybridization, with the inherent lacunae associated with these techniques for signal localization. Our group has studied EBV association with breast cancer by using in situ hybridization for detecting nonpolyadenylated EBV RNA (EBERs), along with using protein localization technique of immunohistochemistry, studying the EBV nuclear antigen 1 (EBNA1) and the latent membrane proteins (LMP1 and LMP2A). This is the first article analyzing the expression of LMP2A in breast cancer cells. In all of our 43 female breast cancer cases under study, we failed to detect expression of any of the EBV viral gene products tested.


Asunto(s)
Neoplasias de la Mama/virología , Antígenos Nucleares del Virus de Epstein-Barr/análisis , Herpesvirus Humano 4/aislamiento & purificación , ARN Viral/análisis , Proteínas de la Matriz Viral/análisis , Neoplasias de la Mama/patología , Femenino , Herpesvirus Humano 4/genética , Humanos , Inmunohistoquímica , Hibridación in Situ , Reacción en Cadena de la Polimerasa
18.
Pathobiology ; 70(6): 343-7, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12865630

RESUMEN

OBJECTIVE: The monoclonal antibody (mAb) designated as mAb Das-1 was generated against a colonic epithelial protein. It reacts with bronchiolar epithelium and submucosal glands and weakly with alveolar lining cells of fetal lung. Adult alveolar epithelium is, however, nonreactive for mAb Das-1. The present study was designed to evaluate the immunoexpression of Das-1 and to correlate it with the histomorphology of primary lung adenocarcinomas and intestinal metaplasia. METHODS: Eighty-four cases of primary lung adenocarcinomas were reviewed and categorized according to histologic grade and subtype. Immunohistochemical staining with mAb Das-1 was performed with normal colon as control. RESULTS: Expression of Das-1 in the submucosal bronchial glands also served as internal control. Strong and diffuse staining was seen in 33 of the 84 cases of adenocarcinomas (39%). CONCLUSIONS: Expression of Das-1 was seen in primary lung adenocarcinomas even though adult alveolar epithelium is negative. Staining with mAb Das-1 was seen regardless of the grade or histological subtype of the lung adenocarcinomas. As most primary lung adenocarcinomas are not of bronchial gland origin, expression of Das-1 represents activation of oncofetal antigens.


Asunto(s)
Adenocarcinoma/metabolismo , Anticuerpos/metabolismo , Antígenos de Neoplasias/biosíntesis , Neoplasias Pulmonares/metabolismo , Adenocarcinoma/patología , Anticuerpos/inmunología , Anticuerpos Monoclonales/inmunología , Biomarcadores de Tumor/metabolismo , Bronquios/metabolismo , Bronquios/patología , Glándulas Exocrinas/metabolismo , Glándulas Exocrinas/patología , Humanos , Técnicas para Inmunoenzimas , Proteínas de Filamentos Intermediarios/metabolismo , Queratina-20 , Queratina-7 , Queratinas/metabolismo , Neoplasias Pulmonares/patología , Mucosa Respiratoria/metabolismo , Mucosa Respiratoria/patología
19.
Cytokines Cell Mol Ther ; 6(2): 81-7, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11108573

RESUMEN

Chimeric CD20 monoclonal antibody as alternative therapy in relapsed low-grade non-Hodgkin's lymphoma (NHL) has produced responses in nearly 50% of patients. Augmenting CD20 expression on tumor cells and/or inducing its expression may increase the cell kill and effectiveness of antibody therapy. Peripheral blood lymphocytes from 19 patients with B-cell chronic lymphocytic leukemia (B-CLL) were incubated in vitro in the presence of interferon-alpha (IFN-alpha) (500 U/ml and 1,000 U/ml) for 24 and 72 hours. The effect on CD20 expression was studied by flow cytometry. The differences in the percentage positivity, the mean fluorescence intensity (MFI), and the product of percentage positivity and MFI were used to assess upregulation. There was a significant upregulation of CD20 expression on B cells seen at both concentrations after 24-hour priming (p < 0.01). B-CLL cells cultured for 72 hours in the presence of IFN-alpha also showed upregulation of CD20 expression; however, the degree of upregulation was much lower than that seen at 24 hours. There was no statistically significant increase in CD20 antigen expression on normal lymphocytes following cytokine exposure. These results suggest that IFN-alpha priming may augment the effectiveness of antibody therapy by directly upregulating CD20 antigen expression in addition to its indirect action through effector cells of the host.


Asunto(s)
Antígenos CD20/sangre , Linfocitos B/inmunología , Interferón-alfa/farmacología , Leucemia Linfocítica Crónica de Células B/inmunología , Antígenos CD/sangre , Antígenos CD/genética , Antígenos CD20/genética , Linfocitos B/efectos de los fármacos , Células Cultivadas , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/inmunología , Humanos , Interferón alfa-2 , Cinética , Leucemia Linfocítica Crónica de Células B/sangre , Proteínas Recombinantes , Valores de Referencia
20.
Microsc Res Tech ; 50(3): 251-7, 2000 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-10891891

RESUMEN

Tumor necrosis factor alpha (TNF alpha) is a pleiotropic cytokine that is constitutively produced by leukemic cells in B Chronic Lymphocytic Leukemia (B-CLL). It has been shown to have autocrine and paracrine functions in normal B cells and in B lymphoproliferative diseases. This study was conducted to determine the effect of TNF alpha (in vitro) on CD20 expression on cells from patients with B-CLL. Currently, anti-CD20 monoclonal antibody therapy is becoming a second line treatment in the management of B cell disorders like low-grade non-Hodgkin's lymphoma (NHL) and B-CLL. Our results demonstrate amply that very low doses of TNF alpha (0. 0125 ng/ml) can be used to significantly increase CD20 expression on cells from patients of B-CLL as evidenced by increases in both percentage positivity and mean fluorescence intensity. The upregulation is evident as early as 24 hours and is maintained for up to 72 hours. We propose that the upregulation is a direct result of in vitro differentiation stimulated by TNF alpha. The results presented can be exploited in the designing of priming protocols prior to antibody therapy and this is discussed.


Asunto(s)
Antígenos CD20/análisis , Leucemia Linfocítica Crónica de Células B/terapia , Factor de Necrosis Tumoral alfa/farmacología , Anticuerpos Monoclonales/uso terapéutico , Antígenos CD20/inmunología , Supervivencia Celular/efectos de los fármacos , Humanos , Leucemia Linfocítica Crónica de Células B/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...